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SUMMARY 19 
Intimin and Invasin are prototypical inverse (Type Ve) autotransporters and important virulence factors 20 
of enteropathogenic Escherichia coli and Yersinia spp., respectively. In addition to a C-terminal 21 
extracellular domain and a β-barrel transmembrane domain, both proteins also contain a short N-22 
terminal periplasmic domain that, in Intimin, includes a lysin motif (LysM), which is thought to mediate 23 
binding to peptidoglycan. We show that the periplasmic domain of Intimin – but not the shorter domain 24 
of Invasin – does bind to peptidoglycan both in vitro and in vivo, but only under acidic conditions. We 25 
present the solution structure of the Intimin LysM, which has an additional, potentially functionally 26 
relevant α-helix compared to other LysMs. In contrast to previous reports, we demonstrate that the 27 
periplasmic domain of Intimin mediates dimerisation. Our data suggests that the periplasmic domain 28 
contains two dimerisation interfaces. We further show that dimerisation and peptidoglycan binding are 29 
general features of LysM-containing inverse autotransporters. The periplasmic domain could be involved 30 
in autotransport, and peptidoglycan binding may aid in resisting mechanical and chemical stress during 31 
transit through the gastrointestinal tract. 32 
 33 
  34 
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INTRODUCTION 35 
An often essential first step in host colonization by bacterial pathogens is the adherence of bacteria to 36 
host cells and tissues. This binding is mediated by various adhesins, many of which are proteinaceous 37 
molecules expressed on the cell surface. Intimin (Int) is a major adhesin of enteropathogenic and 38 
enterohaemorrhagic Escherichia coli (EPEC and EHEC) and is instrumental in the formation of actin 39 
pedestals leading to attaching and effacing (A/E) lesions on enterocytes (Schmidt, 2010). It is a 40 
homologue of Invasin (Inv) from enteropathogenic Yersinia spp., which mediates direct binding to host 41 
cells via 1 integrins (Leo and Skurnik, 2011). However, unlike Inv, Int does not bind primarily to a 42 
cellular receptor; rather, the Int receptor Tir is produced by the bacteria themselves and transferred to 43 
the host cell membrane through the type 3 secretion system (Schmidt, 2010). 44 
The extracellular domain of Intimin consists of tandem immunoglobulin (Ig)-like domains capped by a C-45 
type lectin domain (Kelly et al., 1999). The Tir-binding region is located in the C-terminal superdomain 46 
consisting of the last Ig domain and the lectin domain (Luo et al., 2000). The extracellular portion of 47 
Invasin has a similar structure (Hamburger et al., 1999), and the integrin-binding region is also located at 48 
the C-terminal tip of the protein (Leong et al., 1990). The extracellular or passenger domain of both 49 
proteins is exported by a type Ve or inverse autotransport mechanism: a 12-stranded transmembrane -50 
barrel N-terminal to the passenger domain acts as a translocation pore which facilitates the secretion of 51 
the passenger domain across the outer membrane (Oberhettinger et al., 2012; Leo et al., 2012; Fairman 52 
et al., 2012).  53 
In addition to the passenger and translocation domains, both proteins contain a small N-terminal 54 
periplasmic domain, also referred to as the α-domain (Tsai et al., 2010). In Int, the periplasmic domain 55 
contains a lysin motif (LysM) found in many peptidoglycan-binding proteins (Buist et al., 2008). The LysM 56 
is a small domain consisting of a 2-stranded anti-parallel β-sheet packed against two α-helices with the 57 
topology β-α-α-β (Bateman and Bycroft, 2000). LysMs usually bind to the N-acetylglucosamine moieties 58 
in peptidoglycan (PGN) and chitin, or other carbohydrate structures (Buist et al., 2008). In contrast to 59 
Int, the Inv periplasmic region lacks a LysM. 60 
Due to the presence of a LysM in the Int periplasmic domain, it has long been suspected that the 61 
periplasmic domain would mediate binding to PGN (e.g. Bateman and Bycroft, 2000; Tsai et al., 2010; 62 
Pisano et al., 2012). However, up to now, this hypothesis has not been experimentally validated. In this 63 
study, we show that the periplasmic domain of Int does indeed bind PGN, but only under acidic 64 
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conditions. In addition, we show that the periplasmic domain mediates dimerisation of Int. In contrast, 65 
the shorter periplasmic domain of Inv has neither of these functions. We also present a solution 66 
structure of the Int LysM and show that dimerisation and PGN binding are conserved functions of LysMs 67 
of inverse autotransporters. Dimerisation appears to be an important feature for the virulence function 68 
of these proteins. Our results show that the periplasmic domain of type Ve autotransporters are 69 
functional and may be involved in stabilising the cell envelope and virulence functions. 70 
RESULTS 71 
Bioinformatic analysis of periplasmic domains from inverse autotransporters 72 
Secondary structure prediction of the Int sequence using software of the online Bioinformatics Toolkit of 73 
the Max-Planck Institute for Developmental Biology (http://toolkit.tuebingen.mpg.de/) reveals that the 74 
periplasmic domain contains the LysM motif, consisting of a small β-sheet packed against two α-helices, 75 
followed C-terminally by two closely spaced α-helices (Fig. 1A). There is an unstructured loop of 76 
approximately 30 residues linking the LysM domain to the first of the C-terminal helices, which we call 77 
the spacer sequence. The periplasmic domain of Inv also contains the helices, but lacks the LysM motif 78 
(Fig. 1A). An alignment of selected members of the Inv-Int family periplasmic domains shows that the C-79 
terminal helices are conserved, whereas the LysM motif is only present in some members of the family 80 
(Fig. S1). Similar results were also obtained in an earlier study (Tsai et al., 2010). 81 
To investigate the distribution of different types of periplasmic domains within inverse autotransporters, 82 
we performed clustering analysis of the periplasmic domain sequences using CLANS (Frickey and Lupas, 83 
2004). A total of 172 sequences were included in the clustering (Table S1), and after singletons 84 
(sequences with P-values for BLAST high-scoring segment pairs higher than 0.99) were removed 152 85 
sequences remained. The results (Fig. 1B) show that the periplasmic domains cluster largely based on 86 
taxonomic distribution rather than length or the presence of the LysM motif. Most of the sequences 87 
were derived from the γ-Proteobacteria, especially the Enterobacteriaceae, which form a large cluster. 88 
Int is located close to the centre of this cluster, whereas Inv is located more peripherally (Fig. 1B). Other 89 
distinct clusters are formed by cyanobacterial sequences and sequences from the β-proteobacterial 90 
genus Bordetella. Interestingly, periplasmic domains from the cyanobacterial genus Synechococcus form 91 
two distinct clusters that are only distantly connected to the enterobacterial cluster; however, as the 92 
synechococcal sequences are all very short, the separate clusters may be artefactual. The sizes of the 93 
sequences do not have a large effect on the clustering, as both large and small sequences are found in 94 
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the same clusters (Fig. S2A). The LysM appears restricted to the large γ-proteobacterial cluster, as it was 95 
not detected in any of the other groups (Fig. 1C). The presence of the LysM domain can to some degree 96 
be predicted based on the length of the protein sequence; however, the correlation is not absolute and 97 
there are several large members of the family lacking the LysM motif (Fig. S2B). The prevalence of LysMs 98 
in large inverse autotransporters suggests that the LysM may be involved in the autotransport process, 99 
possibly stabilising translocation intermediates during secretion. 100 
The Int periplasmic domain mediates dimerisation 101 
Int has been reported to form dimers via its β-barrel domain (Touzé et al., 2004). However, the Int β-102 
barrel crystallises as a monomer (Fairman et al., 2012). This suggested to us that the dimerisation might 103 
be mediated by the periplasmic domain, which was included in the construct used by Touzé et al (2004). 104 
To test this, we produced the periplasmic domains of Int (from EPEC) and Inv (from Y. enterocolitica) as 105 
maltose-binding protein (MBP) fusions, named IntPeri-MBP and InvPeri-MBP, with the MBP as a C-106 
terminal fusion and a hexahistidine tag on the N-termini of the periplasmic domains. The constructs are 107 
depicted schematically in Fig. 2A, and all plasmids used in the study are summarised in Table 1. IntPeri-108 
MBP in particular is unstable, and degradation products were observed in cell lysates (data not shown); 109 
however, we were able to purify the proteins to high purity by passing the proteins through both a 110 
nickel and amylose column followed by size exclusion chromatography (SEC). 111 
When we performed analytical SEC at physiological pH (7.4.), MBP and InvPeri-MBP run at the expected 112 
sizes of the monomer, whereas IntPeri-MBP gives two peaks: the major peak migrates at an apparent 113 
size slightly larger than the dimer and the smaller peak at the expected molecular weight of the 114 
monomer (Fig. 2B). Both peaks contain Int-MBP, suggesting an equilibrium between monomeric and 115 
dimeric forms. Indeed, when we reran the major peak through the SEC column, a similar distribution for 116 
dimer and monomer was observed (Fig. S3A).  117 
To further characterise the region in the periplasmic domain responsible for dimerisation, we fused 118 
short fragments of the Int periplasmic domain to MBP (Fig. 2A). These fragments were the LysM domain 119 
along with the spacer sequence (IntLysM-MBP), the two C-terminal helices (IntPeriHelix1-MBP) or just 120 
the second, C-terminal helix (IntPeriHelix2-MBP). In SEC, IntLysM-MBP migrates as a dimer, whereas the 121 
other two constructs run as a monomer (Fig. 2C). This suggests that the N-terminal region of the 122 
periplasmic domain is the dimerisation interface. 123 
6 
 
Touzé and coworkers showed that the β-barrel and flanking regions (residues 189-550) contains a 124 
dimerisation site (Touzé et al., 2004). As the β-barrel itself is monomeric, Fairman et al. speculated that 125 
the dimerisation interface would either be in the periplasmic region or the first extracellular Ig-like 126 
domain (D00) (Fairman et al., 2012). Our results above suggest a dimerisation site in or near the LysM. 127 
We therefore produced and purified the D00 domain and tested its oligomerisation status by SEC. The 128 
domain ran as a monomer (Fig. S4). Thus, the dimerisation observed by Touzé et al must be due to the 129 
short stretch preceding the β-barrel domain (residues 189-209). This corresponds to C-terminal helix in 130 
the periplasmic domain (Helix2). This helix failed to dimerise when fused to MBP, but it is possible that 131 
the helix is not correctly folded outside its native context. We therefore submit that the Int periplasmic 132 
domain contains two dimerisation interfaces, the LysM region and Helix2, though the latter only 133 
mediates dimer formation when fused to the β-barrel.  134 
The periplasmic domains of Int and Inv promote surface display of the passenger domain 135 
To investigate the relevance of the periplasmic domain under in vivo conditions, we produced deletion 136 
mutants of Inv and Int in E. coli. We used full-length, wild-type (wt) Int and a construct missing the entire 137 
periplasmic domain (IntPeri). We did the same for Inv (Inv wt and InvPeri), and bacteria with the 138 
empty vector (pASK-IBA2) acted as our negative control. In addition, we made two chimaeric constructs: 139 
IntPeri-Inv, where the periplasmic domain of Inv was switched to that of Int, and InvPeri-Int, where the 140 
Int periplasmic domain was replaced with the Inv periplasmic domain. These constructs are summarized 141 
schematically in Fig. 3A.  142 
To determine whether the truncations had a major effect on Int biogenesis, we examined the surface 143 
display of the Int passenger by both fluorescence-activated cell sorting (FACS) and immunofluorescence 144 
microscopy. Both Int wt and Inv wt were exported to the surface (Fig. 3B). The Peri constructs were 145 
also surface-exposed but displayed a bimodal distribution, with a part of the population exhibiting lower 146 
fluorescence. This may be due to impaired secretion of the passenger domain. In contrast, the 147 
chimaeras were more fluorescent than the corresponding wt constructs, suggesting higher expression 148 
levels or more efficient surface display. The reason for this is unclear. 149 
We also examined the effect of the truncations and domain switching on adhesion and induction of 150 
interleukin (IL)-8. For Int, we performed qualitative adhesion assays, where we examined the adherence 151 
of the omp2 strain containing the Int constructs to HeLa cells that had been preinfected with a eaeA 152 
EPEC strain to prime the cells with Tir (Oberhettinger et al., 2012). The wild-type construct adhered 153 
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strongly to preinfected cells, but not to uninfected cells (Fig. 3C). However, IntPeri showed much lower 154 
adhesion than the wt, probably because of reduced surface display, but possibly also because of 155 
reduced avidity through the loss of dimer formation (Fig. 3C). The chimaeric construct InvPeri-Int 156 
promoted intermediate adhesion; stronger than IntPeri, but not as strong as the wt, despite high 157 
surface exposure. We assume this is due to the lack of dimer formation and thus a loss of co-operativity 158 
in the Int-Tir interaction (Touzé et al., 2004). The empty vector served as a background control.  159 
For the Inv constructs, we measured the induction of IL-8 production in infected cells with an enzyme-160 
linked immunosorbent assay (ELISA). Wild-type Inv induced IL-8 well over background levels, as did the 161 
positive control tumor necrosis factor (TNF) (Fig. 3D). The vector control was barely above background 162 
levels, and IL-8 production by InvPeri was reduced compared to the wt. However, IntPeri-Inv showed 163 
significantly higher induction of IL-8 than even TNF. This increase is presumably largely due to the Int 164 
periplasmic domain mediating dimerisation of Inv, but the higher levels of IntPeri-Inv on the surface may 165 
also have an effect (Fig. 3B). In Y. pseudotuberculosis, Inv contains an additional extracellular domain 166 
(D2) that mediates self-association and leads to more efficient bacterial uptake than in Y. enterocolitica 167 
(Dersch and Isberg, 1999; Dersch and Isberg, 2000). In the chimaeric IntPeri-Inv, the Int periplasmic 168 
domain could thus fulfil a role similar to D2, leading to dimerisation which in turn promotes receptor 169 
clustering, more efficient cell invasion and higher IL-8 levels.  170 
The periplasmic domain of Int, but not Inv, binds peptidoglycan in a pH-dependent manner 171 
We performed pull-down assays with our MBP fusions using purified PGN sacculi from E. coli to 172 
determine whether the Int periplasmic domain binds PGN (Fig. 4). We fortuitously found that binding 173 
was strongest at low pH: in assays performed at pH 5.0, approximately half the IntPeri-MBP fusion 174 
precipitates with the sacculi, while the MBP control remain in the supernatant (Fig. 4A). In this assay, 175 
Inv-MBP displayed only background-level binding to PGN (Fig. 4A). In the absence of PGN, all three 176 
proteins remained soluble. At normal physiological pH (7.4), however, we saw no binding of IntPeri-MBP 177 
to PGN, with most of the protein remaining in the supernatant (Fig. 4A).  178 
To examine the effect of pH on the binding of IntPeri-MBP to PGN more systematically, we performed 179 
binding at range of pH values between 8.0 and 3.0; strong binding first became evident at pH 6.0 and 180 
the ratio of bound IntPeri-MBP to soluble protein remains constant even with reduction in pH value (Fig. 181 
4B). In the control experiment without PGN sacculi, the protein remains soluble at all pH values tested 182 
(Fig. 4B). We observed similar results with a glutathione-S-transferase (GST) fusion of IntPeri; however, 183 
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GST itself tends to precipitate at low pH, which made interpreting these results difficult (data not 184 
shown). Int-MBP still dimerises at pH 4.0 (Fig. S3B), demonstrating that dimerisation is independent of 185 
pH.  186 
Physiologically abundant divalent cations (Ca2+, Mg2+, Mn2+, Zn2+) might have an effect on the binding of 187 
IntPeri to PGN. To check this, we added these ions as chloride salts to the pull-down assay, and in 188 
addition we tested the effect of the chelators ethylene diamine tetra-acetic acid (EDTA) and sodium 189 
citrate. However, neither the divalent cations nor the chelators had an effect on binding, though some 190 
of the ions, particularly Ca2+, slightly modified the pattern of migration in SDS-PAGE (Fig. 4C). We 191 
therefore conclude that the binding of IntPeri to peptidoglycan is pH-dependent but does not require 192 
divalent ions.  193 
We partially digested peptidoglycan sacculi with mutanolysin and performed a competition assay with 194 
the soluble digestion products. Addition of the degradation products inhibited the binding of IntPeri-195 
MBP to the sacculi in a dose-dependent manner, though we did not observe complete inhibition of 196 
binding to sacculi (Fig. 4D). This demonstrates that soluble muropeptides can compete for binding to 197 
IntPeri-MBP. Many LysM-containing proteins also bind chitin (Buist et al., 2008). We therefore ran 198 
IntPeri-MBP, InvPeri-MBP and MBP as a control through a chitin column. However, we did not observe 199 
binding for any of the constructs (Fig. 4E). This suggests that IntLysM binds to other determinants in PGN 200 
than the N-acetylglucosamine – N-acetylmuramic acid backbone.  201 
To find out which part of the periplasmic domain of Int is responsible for PGN binding, we performed 202 
pull-down assays with IntLysM-MBP, IntPeriHelix1-MBP and IntPeriHelix2-MBP (Fig. 4F). In this assay, 203 
only IntLysM-MBP coprecipitated with the sacculi in appreciable amounts, demonstrating that it is 204 
indeed the LysM that mediates PGN binding. 205 
As we saw some background levels of InvPeri-MBP bound to PGN, we wished to further investigate the 206 
relative affinities of InvPeri-MBP and IntPeri-MBP. To this end, we performed pull-down assays using a 207 
concentration series of IntPeri-MBP and InvPeri-MBP with a constant amount of PGN. At low 208 
concentrations of IntPeri-MBP, almost all the protein is pulled down with the sacculi, whereas the 209 
fraction in the pellet decreases steadily with increasing protein concentration (Fig. 5A). InvPeri-MBP 210 
follows a similar trend, but even at low concentrations only approximately 50% is pulled down with the 211 
sacculi, and at higher concentrations less than 20% remains in the pellet (Fig. 5A). In the reverse 212 
experiment, where we varied the concentration of PGN but kept the protein concentration constant, 213 
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only a small fraction of IntPeri-MBP precipitates with low amounts of PGN, but as the amount of PGN 214 
rises, increasingly more IntPeri-MBP is found in the pellet (Fig. 5B). The increase in roughly linear, and at 215 
the highest concentration tested (50 µg), 75% of the protein is in the pellet. Again, InvPeri-MBP follows a 216 
similar trend, but the increase in the fraction of pelleted protein is not as large, and at most only 30% of 217 
the protein was pulled down with the sacculi (Fig. 5B). It appears that IntPeri-MBP binds with high 218 
affinity to PGN, as most of the protein precipitates at low protein concentration. However, the fraction 219 
of bound protein declines more or less linearly with increasing concentration of IntPeri-MBP, which we 220 
interpret to mean that there are a limited number of high-affinity binding sites in the sacculi and that 221 
these are quickly saturated. The amount of IntPeri-MBP scales linearly with increasing PGN, which is 222 
consistent with this interpretation. However, also InvPeri-MBP follows similar trends, though the 223 
binding levels are much lower than for IntPeri-MBP. When we incubated sacculi with both IntPeri-MBP 224 
and InvPeri-MBP, we did not see any effect of high concentrations of InvPeri-MBP on the binding levels 225 
of IntPeri-MBP, suggesting that these proteins do not compete for the same binding site(s) and that the 226 
binding of InvPeri-MBP is indeed unspecific (Fig. S5). The results obtained using concentration series of 227 
either protein or PGN should be viewed with caution, however, as the assays used are rather crude and 228 
include washing steps which we did not take into account when calculating the relative binding, and 229 
even in the absence of PGN we often observe faint background bands in the pellets (Fig. 4). In addition, 230 
the pull-down assays do not cover a wide enough range to estimate reliable dissociation constants. Our 231 
tentative conclusions are therefore that IntPeri-MBP binds with high affinity to a finite number of 232 
binding sites, whereas a small amount of InvPeri-MBP precipitates unspecifically with the sacculi, though 233 
we cannot rule out some specific but low-affinity interaction. Unfortunately, we could not use more 234 
sophisticated biophysical methods such as surface plasmon resonance to more accurately estimate the 235 
dissociation constants due to the difficulty of immobilising sacculi on detector chips. 236 
The Int periplasmic domain binds to PGN in vivo  237 
To determine whether the Int periplasmic domain can mediate PGN binding in vivo, we cloned the MBP 238 
fusions into pIBA2C, which contains a signal sequence for periplasmic targeting. We used 239 
chloramphenicol selection rather than ampicillin in order to avoid any structural changes to PGN. The 240 
protein was expressed in medium buffered at either pH 7.4 or pH 5.5. To see if the MBP fusion proteins 241 
bound to PGN, we extracted the periplasmic fraction by osmotic shock. All solutions were buffered at 242 
either pH 7.4 or pH 5.5. We then detected the protein by Western blot using an anti-MBP antiserum. For 243 
the whole-cell samples of IntPeri-MBP, a strong band is evident at ~65 kDa, as expected, along with a 244 
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small amount of apparent degradation products (Fig. 6A). We assume the 65 kDa band corresponds to 245 
intact IntPeri-MBP. At pH 7.4, this band is also in the periplasmic fraction, but at pH 5.5 the 65 kDa band 246 
is barely visible. InvPeri-MBP is less stable, with two stronger bands: ~50 kDa, which is presumably the 247 
intact protein, and ~45 kDa, which we assume is a degradation product. Both bands are present at 248 
similar levels in all samples. The vector control does not display any bands, demonstrating the specificity 249 
of the antiserum, whereas in our control for periplasmic extraction (pIBA2C-MBP), the MBP band (41 250 
kDa) is present in all the samples at an equal intensity. As the 65 kDa IntPeri-MBP band is present in the 251 
periplasmic fraction at pH 7.4 but not at pH 5.5, we interpret this to mean that at pH 5.5, IntPeri-MBP is 252 
retained in the periplasm due to PGN binding. This finding is consistent with our pull-down assays, as is 253 
the observation that InvPeri-MBP is extracted at similar amounts at both pH values, which supports the 254 
conclusion that it does not bind to PGN.  255 
Structure of the Intimin LysM  256 
To date, there is no structural information about the inverse autotransporter periplasmic domains. To 257 
structurally characterise the periplasmic domain, we produced and purified the N-terminal region of the 258 
Int periplasmic domain (residues 40-153). We did this by producing the protein as a fusion with MBP, 259 
followed by cleaving the MBP from the Int fragment with tomato etch virus (TEV) protease. This region 260 
contains the predicted LysM domain (residues 63-114) and putative dimerisation interface (Fig. 2C). We 261 
then proceeded to solve the solution structure of this region using nuclear magnetic resonance (NMR) 262 
spectroscopy.  263 
When measuring the NMR spectra, we noted the rapid decay of several signals with shifts suggesting a 264 
structured environment and the appearance of others more consistent with unstructured protein chain. 265 
The signals appearing were assigned to the C-terminus of the protein, i.e. in the spacer sequence. 266 
Despite extensive efforts, we could not obtain high-resolution structural information from the transient 267 
signals, although chemical shifts suggest that this region has considerable β-sheet content. We conclude 268 
that this structure is unstable and unfolds once the C-terminal fusion partner is removed. At equilibrium, 269 
both the N-terminus (residues 40-60) and the C-terminus (residues 115-143) are disordered (Fig. 7A). 270 
However, the LysM itself was well defined (Fig. 7A). The NMR constraint and refinement statistics are 271 
presented in Table S2. It is noteworthy that we could not detect the dimerisation interface in NMR 272 
measurements on mixtures of differentially labelled protein. This is probably due to the unfolding of the 273 
spacer sequence that presumably contains the dimerisation site. 274 
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The overall fold of the Int LysM is the typical β-α-α-β seen in other LysM structures (Fig. 7B). A Cα 275 
superposition of the various LysMs shows that the main chain conformation is largely similar (Fig. 7C), 276 
with the root mean square deviation (RMSD) between the different structures and the Int LysM varying 277 
from 1.28 Å to 3.62 Å. Most of the LysM structures have an RMSD between 1.5 and 2.5 Å; the furthest 278 
outliers are the hypothetical human protein SB145 (Protein database ID 2DJP) at 2.75 Å and the gpX 279 
LysM from coliphage P2 (2LTF; (Maxwell et al., 2013)) with an RMSD of 3.62 Å. The closest structure is 280 
from the putative (trans)peptidase YkuD from Bacillus subtilis (Bielnicki et al., 2006). Though there are 281 
no major differences between the current LysM domain structures, the Int LysM does contain a short α-282 
helix connecting the structurally conserved C-terminal α-helix and the C-terminal β-strand (Fig. 7C). 283 
Though gpX some other LysMs have a helical turn in this region, these are not as long and defined as the 284 
α-helix in the Int LysM. This extra helix was predicted by bioinformatics (Fig. S1), and appears conserved 285 
within the inverse autotransporter LysMs, suggesting it has some function. Future work will be needed 286 
to uncover the relevance of this α-helix.  287 
PGN binding and dimerisation are general features of LysM-containing inverse autotransporters 288 
Several inverse autotransporters from the Enterobacteriaceae contain a periplasmic LysM domain (Fig. 289 
1). To test whether binding to PGN and dimerisation are general features of inverse autotransporter 290 
LysMs, we cloned the LysM-containing periplasmic domain from an Inv homologue from the fish 291 
pathogen Yersinia ruckeri (GI: 238705545), which we refer to as YrInv for Y. ruckeri Invasin. We 292 
produced the periplasmic domain as an MBP fusion (YrInvPeri-MBP). During later purification steps, we 293 
noticed that in SDS-PAGE, the band of the expected size (58 kDa) began to lose intensity and a new band 294 
migrating at ~200 kDa appeared, and almost all the protein was in this higher molecular-weight band 295 
after the SEC step. This suggested to us that YrInv was forming multimers stabilised by disulphide 296 
bridges, which were not disrupted in our SDS-PAGE experiments because we do not routinely add 297 
reducing agent to our sample buffer. When we used reducing sample buffer, all the protein previously in 298 
the ~200 kDa band ran at the expected size of the monomer, showing that the multimer resulted from 299 
the formation of disulphides by oxidation during purification (Figure 8A). Indeed, there is a single 300 
cysteine in the periplasmic domain in the spacer sequence between the LysM and Helix1 which 301 
presumably mediates the disulphide formation (Fig. 8D). When we performed analytical SEC, YrInvPeri-302 
MBP migrated with an apparent size of ~240 kDa (Fig. 8B). However, if the buffer was supplemented 303 
with dithiothreitol (DTT), the protein migrated with an apparent molecular weight of 91 kDa (Fig. 8B). As 304 
the expected size of the monomer is 58 kDa, we interpret the 91 kDa peak to represent the dimeric form 305 
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of the molecule. The 240 kDa peak seen under non-reducing conditions would therefore correspond to a 306 
tetrameric molecule, i.e. a dimer of dimers stabilised by disulphides. We are not sure whether this 307 
tetramer represents the physiological quaternary structure of YrInv, as we were unable to express the 308 
full-length protein in E. coli. Though this tetramer could be an artefact of the purification procedure, it 309 
seems more likely that the tetrameric form is the physiologically relevant one, as the tetramer of 310 
YrInvPeri-MBP forms quantitatively in the presence of oxygen, and disulphides would be formed in the 311 
periplasm. Interestingly, in addition to dimerising, Inv from Y. pseudotuberculosis also forms tetramers 312 
(Dersch and Isberg, 1999), further pointing towards the interpretation of the tetramer being the 313 
physiologically relevant form of YrInv. 314 
We also performed pull-down assays with PGN sacculi. In the pull-down assay, approximately half the 315 
protein precipitated with the sacculi at pH 5.0, similar to Int, whereas in the control reaction the protein 316 
remained soluble (Fig. 8C). Addition of DTT did not have a significant effect on the amount of protein in 317 
the pellet fraction, suggesting that the tetrameric form is not required for PGN binding (Fig. 8C). 318 
Interestingly, similar to Int, YrInvPeri-MBP did not bind to PGN at pH 7.4 (Fig. 8C). These results show 319 
that also YrInv-MBP dimerises, and probably further tetramerises, and binds to PGN. This suggests that 320 
dimerisation and PGN binding are general properties of LysM-containing periplasmic domains of inverse 321 
autotransporters, and that the pH dependence of the PGN interaction may also be a general feature. 322 
DISCUSSION 323 
PGN binding by the Intimin LysM  324 
Here, we provide the first experimental evidence to show that the Int periplasmic region has affinity for 325 
PGN. In addition, we present the NMR structure of the Int LysM, giving the first structural information 326 
on an inverse autotransporter periplasmic domain. Using pull-down assays with purified PGN sacculi, we 327 
were able to experimentally show, for the first time, that the LysM of the Int periplasmic domain 328 
mediates binding to PGN, whereas the periplasmic domain from Inv did not bind with appreciable 329 
affinity. In our in vivo experiments, InvPeri-MBP was efficiently extracted from the periplasm at pH 5.5., 330 
whereas IntPeri-MBP was retained. These data all point to IntPeri binding strongly to PGN, whereas 331 
InvPeri binds only at low levels, which we contend represent unspecific background binding. An arguable 332 
shortcoming of our experiments is that were not able to test the binding of InvPeri to PGN from Y. 333 
enterocolitica. However, the composition of PGN from E. coli and Y. enterocolitica is very similar, though 334 
there is some variation in the relative abundance of specific muropeptides (Quintela et al., 1995). This 335 
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suggests that if Inv did bind with high affinity to PGN, we would see stronger binding in our experiments. 336 
This view is supported by the fact that YrInvPeri clearly does bind to PGN from E. coli (Fig. 7). Our 337 
conclusion is therefore that only LysM-containing inverse autotransporter periplasmic domains mediate 338 
PGN binding. 339 
Most LysM-containing proteins that have been studied bind to the carbohydrate backbone of PGN, and 340 
many also bind to the N-acetylglucosamine backbone of chitin. However, we did not detect any binding 341 
to chitin beads. Furthermore, although we observed strong binding by IntPeri-MBP to purified sacculi, 342 
the binding saturates at a rather low concentration of protein in relation to PGN (Fig. 5). This would 343 
suggest that either the affinity is low, or the affinity is high and there are only a limited number of 344 
binding sites available for Int. Our data points to the latter explanation; IntPeri-MBP does not bind to 345 
chitin, which suggests to us that the PGN carbohydrate backbone alone is not the target of the Int LysM 346 
domain, but that some particular muropeptide or combination of crosslinked PGN strands is required for 347 
binding. The dimerisation of the LysM may have something to do with the specific binding: it could 348 
either position the two PGN binding sites of the dimer in such a way that the protein can optimally 349 
interact with the specifically crosslinked strands, or dimerisation increases the affinity of the dimer for 350 
PGN. In contrast to inverse autotransporters, many PGN-binding proteins contain several LysMs in 351 
tandem (Buist et al., 2008). Dimerisation may thus be a mechanism to increase the number of PGN 352 
binding units and thereby the strength of the interaction. We are now pursuing further characterisation 353 
of the binding determinants for the Int periplasmic domain in PGN. 354 
The dimerisation interface(s) 355 
We demonstrate here that the Int periplasmic domain is a dimerisation interface for Int. This is in 356 
contrast to a previous report implicating the -barrel domain as the dimerisation interface (Touzé et al., 357 
2004). However, Fairman et al. have shown that the -barrel alone does not dimerise (Fairman et al., 358 
2012), which suggests that the dimerisation is mediated by the regions immediately upstream or 359 
downstream of the -barrel domain. We tested whether the N-terminal Ig-like D00 domain forms 360 
dimers, but our SEC experiments show that it does not. Therefore, the dimerisation observed by Touzé 361 
et al. is probably due to the C-terminal helix (Helix2) of the periplasmic domain. However, this region of 362 
the periplasmic domain does not mediate dimerisation when fused N-terminally to MBP. A likely 363 
explanation for this discrepancy is that Helix2 is intimately connected to the -barrel domain, and 364 
therefore protease-resistant, as shown by Touzé et al. (2004). When fused to MBP, these connections 365 
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are lost and the helix remains either unfolded or misfolded and thus cannot mediate dimerisation. This 366 
finding is supported by the observation that both IntPeri-MBP and IntHelix2-MBP were prone to 367 
degradation.  368 
We also observed clear dimerisation by the LysM region alone, a finding has not been reported before. 369 
Both the full periplasmic domain and the N-terminal, LysM-containing region mediated dimerisation in 370 
SEC experiments when fused to MBP. A notable feature of these experiments was that the dimeric form 371 
was in equilibrium with the monomeric form. This is in contrast to the findings of Touzé et al., who only 372 
observed obligate dimerisation of Int. 373 
Though our SEC experiments show clear evidence for the N-terminal region of IntPeri mediating 374 
dimerisation, unfortunately we did not observe dimers when solving the solution structure. This is most 375 
likely due to the unfolding of the C-terminal spacer element upstream of the LysM. This region may 376 
require a C-terminal anchor (Helix1 under native condition, or MBP in our constructs) to fold stably. The 377 
instability of this region outside its native context could explain why we saw an equilibrium between the 378 
dimeric and monomeric states in SEC. We thus conclude that it is not the LysM itself that is the 379 
dimerisation interface, but the upstream sequence. This conclusion is supported by the fact that 380 
YrInvPeri forms disulphide-bonded tetramers. The single cysteine in the periplasmic domain is located in 381 
the spacer sequence, suggesting that this region is in fact the dimerisation (or oligomerisation) interface. 382 
That the periplasmic domain of YrInv also mediates oligomerisation suggests that oligomer formation is 383 
a general feature of LysM-containing inverse autotransporters. In the case of YrInv, the physiological 384 
relevance of the disulphide-bonded tetramer remains to be determined.  385 
In conclusion, we present a new model for Int dimerisation, where the LysM of the periplasmic domain 386 
is the dimerisation interface, with two sites for dimer formation: Helix2 and the spacer sequence 387 
between the LysM and Helix1 (Fig. 9). This is a modification of the earlier model of Touzé et al. (2004), 388 
which suggested that a single Int dimer interacts with two separate Tir dimers, leading to a reticular 389 
array of Int-Tir interactions and receptor clustering. This is consistent with the crystal structure of Int-Tir, 390 
where the Int monomers jut out from the Tir dimer in opposite directions (Fig. 8) (Luo et al., 2000).  391 
Biological implications 392 
What might be the function of PGN binding in a subset of inverse autotransporters? One possibility 393 
might be to anchor the protein to specific sites in PGN and thus prevent lateral diffusion in the outer 394 
membrane. This could be useful for A/E pathogens, such as EPEC, for pedestal formation and in 395 
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maintaining intimate attachment to host cells. Another interesting facet of the Int-PGN interaction is the 396 
dependence on low pH, which appears to be a conserved feature based on our results with YrInv. The 397 
pH dependence of inverse autotransporter LysM binding suggests that charged residues are involved in 398 
binding. IntPeri has a calculated isoelectric point (pI) of 8.7, and YrInvPeri has a pI of 6.1. Thus, at pH 5.0, 399 
both proteins carry a net positive charge which may play a role in PGN binding. A similar result was 400 
obtained for AcmD, an autolysin from Lactococcus lactis containing three LysMs, where binding to the 401 
cell wall was only detected below the pI of the protein (Visweswaran et al., 2013). Interestingly, Int is 402 
upregulated under acid stress (House et al., 2009). As EPEC and other A/E pathogens must travel 403 
through the stomach to reach the intestine, and the pH of the periplasm closely follows the pH of the 404 
extracellular medium (Wilks and Slonczewski, 2007), the periplasm will experience a significant drop in 405 
pH during the pathogen’s journey through the stomach. The binding to PGN may help in stabilising the 406 
cell envelope and aid in acid resistance; however, our attempts to probe the acid resistance of Int-407 
expressing bacteria using survival assays did not yield any conclusive results compared to control cells 408 
(data not shown). 409 
The function of PGN binding and dimerisation remain unclear. The model proposed by Touzé et al. 410 
(2004) suggests that Int dimerisation leads to more efficient Tir clustering on the host cell membrane 411 
and the initiation of downstream effects. Purified Int passenger domain can also lead to actin 412 
rearrangements (Liu et al., 1999), but these experiments were carried out using a GST fusion, and GST 413 
forms dimers, which could explain this observation. Bacteria expressing periplasmically truncated Int or 414 
InvPeri-Int did not bind as strongly to HeLa cells as wt Int, possibly due to less surface exposure of the 415 
protein in the case of IntPeri, but potentially as a result of the loss of dimer formation in the case of 416 
the chimaeric protein. Interestingly, a recent study showed that an Inv-Int fusion that binds to Tir failed 417 
to form actin pedestals when expressed in Citrobacter rodentium, and that this strain was defective in 418 
colonising a mouse model (Mallick et al., 2012). As this fusion lacks a dimerisation interface, it is 419 
tempting to speculate that the defects are at least partially due to the protein not forming a functional 420 
dimer. Dimerisation seems to be important for inverse autotransporter function, as it is widely 421 
conserved within the protein family. In contrast to LysM-containing inverse autotransporters, Inv from Y. 422 
pseudotuberculosis forms dimers and tetramers, but in the absence of a LysM (Dersch and Isberg, 1999). 423 
The multimerisation interface is in the D2 Ig-like domain in the passenger region, which is missing in the 424 
Y. enterocolitica orthologue (Dersch and Isberg, 2000). The Y. pseudotuberculosis protein is the more 425 
potent invasin and promotes a stronger cellular response compared to Y. enterocolitica Inv, presumably 426 
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due to receptor clustering (Dersch and Isberg, 2000). Dimerisation of inverse autotransporters thus 427 
appears functionally important and can occur through at least two distinct mechanisms: through 428 
dimerisation of the periplasmic domain or by self-association of domains in the passenger region.  429 
Apart from adhesion, another aspect of the biology of type Ve-secreted adhesins in which the 430 
periplasmic domain might play a role is autotransport. Some of our data supports this hypothesis: 431 
though deletion of the entire periplasmic domain does not abolish surface display, it does reduce it. A 432 
reasonable assumption would therefore be that the conserved C-terminal helices (Helix1 and Helix2) 433 
would play a role in passenger secretion. Additionally, longer inverse autotransporters are more likely to 434 
include a LysM, which might also have a function in the autotransport process. Autotransporters of 435 
some other classes contain periplasmic domains: a few trimeric (type Vc) autotransporters contain 436 
coiled-coil periplasmic extensions, and type Vd-secreted proteins have periplasmic POTRA (polypeptide 437 
transport-associated) domains (Szczesny and Lupas, 2008; Salacha et al., 2010; Arnold et al., 2010). We 438 
are currently investigating the involvement of autotransporter periplasmic domains in passenger 439 
secretion. 440 
EXPERIMENTAL PROCEDURES 441 
Bioinformatic analyses 442 
To identify periplasmic domains of inverse autotransporters, we performed a PSI-BLAST (Altschul and 443 
Koonin, 1998) search with 5 iterations against the non-redundant database using either the Int or Inv 444 
periplasmic domain and -barrel domain sequence. We included the latter to correctly identify type Ve-445 
secreted proteins, and only hits covering over 80% of the query (so as to contain sequence from both 446 
the -barrel and periplasmic domain) were included. The search results were pooled and duplicate hits 447 
removed. The sequences were then checked manually and any clearly false positive results (i.e. those 448 
lacking the -barrel domain) were removed. The remaining sequences (many of which appear to 449 
misannotated in the database) were aligned and the -barrel domains removed based on the alignment. 450 
To identify signal peptide cleavage sites, we submitted the sequences to SignalP 4.0 (Petersen et al., 451 
2011) or Phobius (Käll et al., 2004), and the sequence N-terminal to the consensus cleavage site were 452 
removed. The remaining sequences were then checked for the presence of a LysM motif using HHPred 453 
(Söding et al., 2005). For clustering, we used CLANS (Frickey and Lupas, 2004) with default parameter 454 
values. Alignments and secondary structure analysis were performed using programmes in the MPI 455 
Bioinformatics Toolkit (Biegert et al., 2006)(http://toolkit.tuebingen.mpg.de/). 456 
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Cloning 457 
We amplified the regions of interest from genomic DNA of E. coli O127:H6 strain 2348/69 (for Int), Y. 458 
enterocolitica O:8 strain 8081 (for Inv) or Y. ruckeri strain CECT 4319 (for YrInv) using polymerase chain 459 
reaction (PCR) with Phusion polymerase (Thermo Scientific). Primers were constructed to include N- and 460 
C-terminal BsaI sites for cloning into vectors of the pASK-IBA series (IBA GmbH). For the periplasmic 461 
domains, primers were designed to introduce an N-terminal hexahistidine tag for protein purification. 462 
Primer sequences are available on request. Constructs used in this study are summarised in Table 1. For 463 
producing MBP fusions, we introduced in-frame BamHI and NheI restriction sites after the 3’ end of the 464 
insert by PCR-based site-directed mutagenesis (Byrappa et al., 1995). The MBP coding sequence was 465 
amplified from the plasmid pMal-c2 (New England Biolabs) with primers that introduced BamHI and 466 
NheI sites to the 5’ and 3’-ends, respectively. This product was then cloned into the corresponding sites 467 
in the modified pIBA-ASK plasmids to produce the final fusion construct. For fusion controls, we 468 
amplified MBP with primers introducing BsaI sites and cloned the PCR product into pASK-IBA33 to 469 
include a C-terminal hexahistidine tag for efficient purification. To purify Int LysM alone, we amplified 470 
the IntLysM-MBP insert from pIBA2-IntPeriLysM-MBP with the forward primer lacking the His tag 471 
sequence. This product was then cloned into pASK-IBA33 to introduce a C-terminal His tag on the MBP 472 
moiety, and a TEV site was introduced between the LysM and MBP by site-directed mutagenesis. To 473 
produce domain-swapped Inv and Int constructs, we performed a two-step PCR reaction, where the 474 
primers at the fusion junction where designed to overlap (Barik, 1997). Restriction enzymes were from 475 
New England Biolabs, and T4 DNA ligase from Fermentas. 476 
Bacterial strains and growth media 477 
For cloning, all ligation reactions were transformed into chemically competent E. coli TOP10 (Invitrogen). 478 
For protein overproduction in the cytoplasm, we used the expression strain BL21Gold(DE3) (Novagen). 479 
For surface production, the BL21 derivative strain omp2 was used, which is optimised for outer 480 
membrane protein expression (Prilipov et al., 1998). Bacteria were usually grown in lysogeny broth 481 
medium (LB) (Bertani, 1951) supplemented with ampicillin (100 g/ml) or chloramphenicol (25 g/ml). 482 
For protein production, we used the buffered, rich medium ZYP (Studier, 2005) supplemented with 483 
ampicillin as above.  484 
Protein production and purification  485 
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For production of MBP and MBP fusions, an overnight culture of BL21Gold transformed with the 486 
required plasmid was diluted 1:100 in 1 l ZYP medium and grown to mid-log phase (OD600 ~0.5) at 37 °C, 487 
at which time protein production was induced with anhydrotetracycline (200 ng/ml).The cultures were 488 
then grown for another 3 hours at 37 °C after which the cells were harvested by centrifuging (10 489 
minutes 5000 x g) and then resuspended in Ni binding buffer (20 mM sodium phosphate, 20 mM 490 
imidazole, 500 mM sodium chloride, pH 7.4). We added MgCl2 and MnCl2 to 1 mM, lysozyme to 0.1 491 
mg/ml, EDTA-free complete protease inhibitor cocktail (Roche) and a pinch of DNase I (Applichem) and 492 
proceeded to rupture the cells using a French pressure cell with two passes at 18 000 p.s.i. Cellular 493 
debris were pelleted for 1 hour at 100 000 x g, the supernatant was passed through a 0.22 µm filter and 494 
applied to a nickel iminodiacetic acid column (PrepEase; USB). Bound proteins were eluted with a step 495 
gradient of imidazole (250 mM) in Ni binding buffer. We pooled the fractions containing the periplasmic 496 
domain-MBP fusions, added protease inhibitor cocktail and applied these to an amylose column 497 
(MBPTrap; GE Healthcare) equilibrated with 20 mM Tris, 200 mM NaCl, 1 mM EDTA at pH 7.4. Bound 498 
protein was eluted using the same buffer supplemented with 10 mM maltose. Proteins were further 499 
purified by size exclusion chromatography (Superdex200™ 26/60 column; GE Healthcare) in Tris-500 
buffered saline (TBS; 20 mM Tris pH 7.4 with 150 mM NaCl and 0.02% NaN3).  501 
For producing isotope-labeled protein for NMR experiments, we grew cells overnight in minimal 502 
medium M9 (Hochuli et al., 2000) supplemented with 1% LB and ampicillin at 100 µg/ml. The cultures 503 
were then diluted 1:200 in 2 l of M9 + 1% LB + ampicillin containing 15NH3Cl and 
13C-glucose (Sigma). 504 
Once the cultures reached mid-log phase, protein production was induced and the cultures were 505 
harvested after 3 hours at 37 °C. The cells were resuspended in Ni binding buffer and lysed as above. 506 
After passing over a nickel column, the eluted protein was dialysed overnight against phosphate-507 
buffered saline (PBS; 20 mM phosphate pH 7.4, 150 mM NaCl). The following morning, TEV protease 508 
(produced according to (Tropea et al., 2009) was added to 1/10 of the concentration of sample protein 509 
as estimated by absorbance at 280 nm. The digestion was allowed to proceed for 4 hours at room 510 
temperature, after which the digested protein was passed over the nickel column again. The flow 511 
through contained the digested, labeled protein. This was further purified by size exclusion 512 
chromatography using a Superdex75TM 16/60 column (GE Healthcare) equilibrated with PBS. 513 
For outer membrane expression, overnight cultures were diluted 1:100 in 20 ml ZYP medium and grown 514 
till mid-log phase at 37 °C. The temperature was then adjusted to 27 °C and protein production was 515 
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induced with anhydrotetracycline (50 ng/ml). The cells were grown for approximately two hours at 27 °C 516 
before harvesting. 517 
NMR structure determination 518 
All spectra were recorded at 298 K on Bruker AVIII-600 and AVIII-800 spectrometers. Backbone 519 
sequential assignments were completed using a strategy based on a 3D-HN(CA)NNH experiment 520 
(Weisemann et al., 1993). Aliphatic sidechain assignments were completed with standard TOCSY-based 521 
experiments, while aromatic assignments were made by linking aromatic spin systems to the respective 522 
C

H2 protons in a 2D-NOESY spectrum. Stereospecific assignments and the resulting 1 rotamer 523 
assignments were determined from a combination of HNHB and HA[HBHN](CACO)NH experiments (Löhr 524 
et al., 1999). 525 
Distance data were derived from a set of five 3D-NOESY spectra, including the heteronuclear edited 526 
NNH-, CCH-, and CNH-NOESY spectra (Diercks et al., 1999) in addition to conventional 15N- and 13C-527 
HSQC-NOESY spectra. A 12C-filtered 2D-NOESY spectrum was recorded for the observation of contacts to 528 
aromatic groups. Backbone dihedral angle restraints were derived using the TALOS+ server (Shen et al., 529 
2009). Generic backbone dihedral restraints designed to restrict residues to allowed regions of the 530 
Ramachandran map and well-populated sidechain rotamers were applied for unstructured residues.  531 
Hydrogen bond restraints were applied as pseudo-covalent bonds, as outlined in (Truffault et al., 2001). 532 
Refinement was carried out by comparing experimental and back-calculated NOESY spectra using in-533 
house software. Strips were back calculated for the amide protons of all ordered atoms, plus selected 534 
sidechain groups. These were compared to the experimental spectra to confirm backbone and sidechain 535 
dihedral angles and to extract additional distance restraints. 536 
Structures were calcuated with XPLOR (NIH version 2.9.4) using standard protocols with modifications 537 
for the inclusion of H-bonds as pseudo-covalent bonds. For the final set, 100 structures were calculated 538 
and 18 chosen on the basis of lowest restraint violations. An average structure was calculated and 539 
regularized to give a structure representative of the ensemble. Details of the input data and the final 540 
ensemble are given in Table S2. 541 
Surface display and functional controls 542 
Immunofluorescence microscopy, FACS, pre-infection adhesion assays and ELISA for IL-8 production 543 
were all performed as described (Oberhettinger et al., 2012). 544 
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Analytical size exclusion chromatography 545 
Gel sizing was done using a Superdex™200 10/300 column (GE Healthcare) equilibrated either with TBS 546 
or acetate-buffered saline (ABS; 20 mM sodium acetate pH 4.0 with 150 mM NaCl). Approximately 1 mg 547 
of protein was applied to the column, and elution was monitored by absorbance at 280 nm. For sizing, a 548 
preparation of standard proteins (Ribonuclease A (13.7 kDa), Conalbumin (75 kDa), Aldolase (158 kDa), 549 
Ferritin (440 kDa) from GE Healthcare) was passed through the column. We then compared the position 550 
of the sample proteins’ peaks to a standard curve drawn based on the elution profile of the standard 551 
mix to obtain apparent molecular weights.  552 
Peptidoglycan and chitin binding  553 
Peptidoglycan sacculi from E. coli Nissle were purified according to the method of Glauner with some 554 
modifications (Glauner, 1988). The lyophilized sacculi were resuspended in ultrapure water (with 555 
sodium azide added to 0.02% w/v) to a concentration of 10 mg/ml. For pull-down assays, 2 l of this 556 
suspension was mixed with 5 g of protein in a total volume of 30 l and incubated for 15 minutes at 557 
room temperature. The buffer used depended on the pH: we used TBS (pH 8.0 or pH 7.4), MOPS-558 
buffered saline (pH 7.0), MES-buffered saline (pH 6.0), ABS (pH 5.0 and pH 4.0) or glycine-buffered saline 559 
(pH 3.0). The sacculi were then pelleted by centrifuging 30 minutes at ~20 000 x g (full speed using a 560 
tabletop centrifuge). The supernatant was carefully removed and the pellet was washed once with the 561 
corresponding buffer. After a second centrifugation step the supernatant was removed and the pellet 562 
was resuspended in 30 l TBS (pH 7.4). For analysis, we added 10 l of 4X non-reducing sample buffer to 563 
the first supernatant fraction and the pellet fraction, boiled the samples for 5 minutes and then loaded 564 
10 l onto a 12% polyacrylamide gel for SDS-PAGE. 565 
For competition experiments, 20 mg of E. coli PGN sacculi were digested with mutanolysin (4000 U; 566 
from Sigma) in a total volume of 800 l PBS for 16 hours at 37 °C. After heat inactivation of the enzyme 567 
(100 °C, 2 min), the undigested PGN was pelleted (30 min at ~20 000 x g) and the supernatant was 568 
transferred to a new tube. The pH of the solution was changed to 5.0 by the addition of 50 l 1 M NaAc 569 
at this pH; the pH of the solution was checked after mixing. An estimated 30-40% of the sacculi were 570 
digested, giving a concentration of ~7 mg/ml of various muropeptides. We used 5, 10, 15, 20 or 25 l of 571 
the muropeptide solution in our competition experiment. The muropeptides and IntPeri-MBP (5 g as 572 
above) were mixed first, and peptidoglycan sacculi were subsequently added. The total volume was 573 
adjusted to 30 l with ABS pH 5.0. The procedure from this point on was as above. 574 
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For the concentration series, we varied the amount of protein between 0.5 g and 10 g. The amount of 575 
peptidoglycan was varied between 2 g to 50 g. The binding buffer was ABS (pH 5.0). The samples 576 
were otherwise treated as above. 577 
Chitin binding was assayed using chitin beads (New England Biolabs). We prepared columns using 2 ml 578 
of the bead slurry and equilibrated with ABS (pH 5.0). We added 1 mg of protein diluted in 1 ml of ABS 579 
and allowed the protein to enter the column by gravity flow. After washing with 10 ml ABS, bound 580 
protein was eluted with 10 ml TBS (pH 7.4), followed by a second elution step with 0.3 M NaOH. A 581 
sample was taken from each step for SDS-PAGE analysis. 582 
In vivo PGN binding 583 
To test for PGN binding in whole cells, we transformed the plasmids pIBA2C-IntPeri-MBP, pIBA2C-584 
InvPeri-MBP or pASK-IBA2C into BL21omp2 cells. The cells were then grown at 37 °C in LB + 585 
chloramphenicol (25 µg/ml) till mid-log, at which time the temperature was changed to 27 °C. Growth at 586 
this temperature in the presence of maltose leads to expression of endogenous MBP in BL21 and its 587 
derivatives (REF). After 30 minutes, recombinant protein production was induced with AHTC (50 ng/ml). 588 
After 1 hour at 27 °C, we added buffer, either Tris pH 7.4 or sodium acetate pH 5.5, to 100 mM. After a 589 
further hour of growth the turbidity of the cultures (OD600) was measured and an amount of cells 590 
corresponding to 10 ml at an OD600 value of 1.0 was harvested by centrifugation (10 minutes 3500 x g). 591 
To examine the soluble periplasmic fraction, we used a modified osmotic shock protocol. The pelleted 592 
cells were resuspended in 400 µl 5 mM CaCl2 with 5 mM buffer (Tris pH 7.4 or sodium acetate pH 5.5) 593 
and incubated on ice for 10 minutes. This step improves the yield of the periplasmic extraction (Chen et 594 
al., 2004). The cells were pelleted (5 minutes at 8000 x g) and then resuspended in 400 µl ice-cold 595 
osmotic shock solution (33 mM buffer, 20 % sucrose, 5 mM EDTA) buffered at either pH 7.4 or pH 5.5, as 596 
above. After 10 minutes incubation at 8 °C with shaking, the cells were centrifuged as above and then 597 
resuspended in 400 µl 5 mM buffer (either Tris pH 7.4 or sodium acetate pH 5.5). The cells were 598 
incubated for 10 minutes with shaking at 8 °C and then centrifuged as above. A sample (120 µl) was 599 
taken from the supernatant, and 40 µl 4 x SDS-PAGE sample buffer was added. This represented the 600 
periplasmic fraction. For the whole-cell sample, we pelleted an amount of cells from the induced culture 601 
corresponding to 120 µl at OD600 = 25, resuspended these in 120 µl PBS and then added 40 µl sample 602 
buffer. 603 
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To probe for the recombinant proteins, we performed a Western blot. The proteins were separated in a 604 
10% polyacrylamide gel and then transferred to a nitrocellulose membrane (Protran BA 85, GE 605 
Healthcare) using a semi-dry apparatus. The membrane was blocked for 30 minutes with 5% fat-free 606 
milk powder in TBS. The primary antibody was a rabbit anti-MBP (anti-MalE) antiserum diluted in 607 
blocking buffer 1:5000. After 1 hour of blocking, the membrane was washed twice 10 minutes with TBS 608 
+ 0.05% Tween20 (TBS-T), and then the secondary antibody (goat anti-rabbit-alkaline phosphatase (AP), 609 
Jackson Immunoresearch) was added at a dilution of 1:10 000 in blocking buffer. The membrane was 610 
washed twice with TBS-T as above, and a final time in AP buffer (100 mM Tris pH 9.5, 100 mM NaCl, 5 611 
mM MgCl2). Chromogenic detection was performed using the AP substrate nitro blue tetrazolium/5-612 
bromo-4-chloro-3-indolyl phosphate (NBT/BCIP), diluted to 33 ng/ml and 17 ng/ml, respectively, in AP 613 
buffer. The reaction was stopped with deionized water once colour had developed. 614 
The anti-MalE antiserum was obtained by immunizing a rabbit with MBP (MalE). The vaccine was 615 
prepared by emulsifying 1 mg MalE protein (denaturated with 1% SDS) with Freund’s adjuvant in the 616 
cold and injected subcutaneously and intramuscularly (hind legs); after four weeks the rabbit obtained a 617 
booster injection and blood was collected with 5-6 days intervals.  618 
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TABLES 747 
Table 1. Plasmids used in this study. 748 
Plasmid Insert sequence Vector Comment Reference/source 
pASK-IBA2 - pASK-IBA2 Expression vector with 
N-terminal OmpA signal 
peptide for periplasmic 
targeting, with ampicillin 
resistance. 
IBA GmbH 
pASK-IBA2C - pASK-IBA2C Expression vector with 
N-terminal OmpA signal 
peptide for periplasmic 
targeting, with 
chloramphenicol 
resistance. 
IBA GmbH 
pASK-IBA3 - pASK-IBA3 Expression vector for 
cytoplasmic expression. 
IBA GmbH 
pASK-IBA33 - pASK-IBA33 Expression vector for 
cytoplasmic expression, 
with C-terminal His tag. 
IBA GmbH 
pIBA2C-IntPeri-
MPB 
Int periplasmic 
domain (residues 
40-212) 
pASK-IBA2C Produces IntPeri with a 
C-terminal MBP fusion; 
includes N-terminal 
signal peptide for 
periplasmic transport. 
This study 
pIBA2C-InvPeri-
MBP 
Inv periplasmic 
domain (residues 
35-93) 
pASK-IBA2C Produces InvPeri with a 
C-terminal MBP fusion; 
includes N-terminal 
signal peptide for 
periplasmic transport. 
This study 
pIBA2C-MBP MBP pASK-IBA2C Produces MBP with N-
terminal signal peptide 
This study 
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for periplasmic 
transport. 
pIBA2-IntLysM Int lacking LysM 
domain (contains 
residues 144-939) 
pASK-IBA2 For production of N-
terminally truncated Int 
at cell surface. 
This study 
pIBA2-IntPeri Int lacking entire 
periplasmic 
domain (contains 
residues 213-939) 
pASK-IBA2 For production of N-
terminally truncated Int 
at cell surface. 
This study 
pIBA2-IntFull Full-length Int 
(without native 
signal peptide; 
residues 40-939) 
pASK-IBA2 For production of full-
length Int at cell surface. 
This study 
pIBA2-
IntPeriHelix1 
Int lacking LysM 
domain and linker 
to first conserved 
helix (contains 
residues 157-939) 
pASK-IBA2 For production of N-
terminally truncated Int 
at cell surface. 
This study 
pIBA2-
IntPeriHelix2 
Int lacking LysM 
domain and first 
conserved helix 
(residues 184-939) 
pASK-IBA2 For production of N-
terminally truncated Int 
at cell surface 
This study 
pIBA2-InvPeri Inv lacking entire 
periplasmic 
domain (residues 
94-835) 
pASK-IBA2 For production of N-
terminally truncated Int 
at cell surface. 
This study 
pIBA2-InvFull Full-length Inv 
(without native 
signal peptide; 
residues 35-835) 
pASK-IBA2 For production of full-
length Inv at cell surface. 
This study 
pIBA33-IntLysM-
TEV-MBP 
Int LysM domain 
(residues 40-153) 
pASK-IBA33 For production of Int 
LysM domain with C-
This study 
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terminal MBP fusion 
separated by TEV site. 
pIBA33-MBP MBP pASK-IBA33 Produces MBP with a C-
terminal His-tag. 
This study 
pIBA3-IntD00 Int D00 domain 
(residues 450-550) 
pASK-IBA3 Produces Int N-terminal 
Ig-like domain  
 
pIBA3-IntLysM-
MBP 
Int LysM domain 
(residues 40-153) 
pASK-IBA3 Produces Int LysM with 
a C-terminal MBP fusion. 
This study 
pIBA3-
IntPeriHelix1-MBP 
2 C-terminal 
helices of Int 
periplasmic 
domain (residues 
157-212) 
pASK-IBA3 Produces conserved 
helices of Int periplasmic 
domain with a C-
terminal MBP fusion. 
This study 
pIBA3-
IntPeriHelix2-MBP 
C-terminal helix of 
Int periplasmic 
domain (residues 
184-212) 
pASK-IBA3 Produces second 
conserved helix of Int 
periplasmic domain with 
a C-terminal MBP fusion. 
This study 
pIBA3-IntPeri-MBP Int periplasmic 
domain (residues 
40-212) 
pASK-IBA3 Produces IntPeri with a 
C-terminal MBP fusion. 
This study 
pIBA3-InvPeri-
MBP 
Inv periplasmic 
domain (residues 
35-93) 
pASK-IBA3 Produces InvPeri with a 
C-terminal MBP fusion. 
This study 
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FIGURES AND LEGENDS 751 
 752 
Fig. 1. Bioinformatic analyses of periplasmic domains of inverse autotransporters. 753 
A. Schematic of structures of Int from EPEC (dark blue) and Inv from Y. enterocolitica (purple). The 754 
periplasmic domains of both contain two conserved helices (Helix1 and Helix2) at the C-terminus. In 755 
addition, the Int periplasmic domain contains a LysM, which is connected to Helix1 by a spacer 756 
sequence. SP = signal peptide. The various domains are not to scale.  757 
B. CLANS clustering of sequences of periplasmic domains from inverse autotransporters. The sequence 758 
dots are coloured according to taxonomy. Int is indicated in yellow and Inv in magenta.  759 
C. Highlighting of LysM-containing proteins in the cluster map from panel B. The sequences used for 760 
clustering are given is Table S1.  761 
  762 
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 763 
Fig. 2. The periplasmic domain of Int mediates dimerisation. 764 
A. Schematic of periplasmic domain-MBP constructs. Fragments from Int are in blue, fragments from Inv 765 
in purple, MBP is in orange and the N-terminal hexahistidine tags in light blue. 766 
B. SEC of Inv and Int periplasmic domains at pH 7.4. The curve for IntPeri-MBP is in blue, InvPeri-MBP in 767 
purple and MBP in orange. The inset shows an SDS-PAGE gel of the peaks. Apparent molecular weights 768 
of the major peaks are indicated. Expected molecular weights are 61 kDa for IntPeri-MBP, 49 kDa for 769 
InvPeri-MBP, and 41 kDa for MBP. 770 
C: SEC of Int periplasmic domain fragments. IntLysM-MBP is in green, IntPeriHelix1-MBP in grey and 771 
IntPeriHelix2-MBP in red. The insets show SDS-PAGE gels of the peaks. Apparent molecular weights of 772 
the major peaks are indicated. Expected molecular weights are 54 kDa for IntLysM-MBP, 49 kDa for 773 
IntPeriHelix1-MBP, and 46 kDa for IntPeriHelix2-MBP. 774 
 775 
 776 
 777 
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 779 
Fig. 3. Effect of Int and Inv periplasmic domain deletions.  780 
A. Schematic of constructs used for cell surface expression experiments. In the chimaeric constructs 781 
IntPeri-Inv and InvPeri-Int, the periplasmic domains of Inv and Int have been switched. 782 
B. Immunofluorescence and FACS measurements for Int and Inv constructs. For the FACS 783 
measurements, mean fluorescence intensity for the constructs is shown as a bar graph on the right. 784 
C. Preinfection adhesion assay for Int constructs. HeLa cells were preinfected with EPEC eaeA and then 785 
incubated with E. coli omp2 expressing Int constructs (right-hand micrographs). Non-preinfected cells 786 
and the vector pASK-IBA2 acted as negative controls. 787 
D. IL-8 induction by Inv constructs. HeLa cells were incubated with E. coli expressing the Inv constructs 788 
from panel A and IL-8 production was measured by ELISA. TNF (0.1 µg) was the positive control, PBS and 789 
cell culture medium were negative controls. Error bars (S.E.M.) are from 3 replicates, stars denote 790 
statistical significance as determined by ANOVA. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***), P < 0.0001 791 
(****). 792 
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 794 
Fig. 4. The Int periplasmic domain binds peptidoglycan under acidic conditions  795 
A. Pull-down assays using purified peptidoglycan (PGN) sacculi from E. coli. IntPeri-MBP, InvPeri-MBP 796 
and MBP were mixed with peptidoglycan sacculi at pH 5.0 (upper gel) or pH 7.4 (lower gel) followed by 797 
centrifugation. Samples were taken from the supernatant (S), and after washing, the resuspended pellet 798 
(P) and separated in SDS-PAGE. Control reactions were without PGN.   799 
B. Pull-down assays of IntPeri-MBP using PGN sacculi in solutions at different pH (upper gel). The lower 800 
gel is a control gel without PGN. S = supernatant, P = pellet. 801 
C. Effect of divalent cations and chelators on PGN binding by IntPeri-MBP. Pull-down assays were 802 
performed in the presence of either divalent cations or the chelators EDTA or sodium citrate at pH 5.0. S 803 
= supernatant, P = pellet. 804 
D. Effect of soluble muropeptides on the binding of IntPeri-MBP to PGN sacculi. Pull-down assays were 805 
performed with increasing amounts (5-25 µl) of mutanolysin-digested PGN at pH 5.0. S = supernatant, P 806 
= pellet. 807 
E. Binding of IntPeri-MBP, InvPeri-MBP and MBP to a chitin column. 1 mg of protein was loaded onto a 808 
chitin column equilibrated at pH 5.0. The flow through (FT) was collected, the column washed with 809 
34 
 
running buffer (w) and bound protein was eluted first with a buffer at pH 7.4 followed by elution with 810 
0.3 M NaOH (OH).  811 
F. Binding of IntLysM-MBP, IntHelix1-MBP and IntHelix2-MBP to PGN sacculi. Pull-down assays were 812 
performed as in panel A at pH 5.0. S = supernatant, P = pellet. 813 
The results shown are representative of at least two repeated experiments. 814 
 815 
  816 
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 817 
Fig. 5. Quantitative comparison of IntPeri-MBP and InvPeri-MBP binding to PGN. 818 
A. Pull-down assays using a concentration series of IntPeri-MBP (upper gel) and InvPeri-MBP (lower gel) 819 
against a constant amount of PGN at pH 5.0. The concentrations of IntPeri-MBP and InvPeri-MBP were 820 
varied between 0.5 µg and 10 µg per reaction. The graph at the bottom shows relative binding of the 821 
proteins to PGN, with the protein concentration expressed as micromoles per litre. Data points from two 822 
replicate experiments represent the band intensity of the pellet divided by the sum of the supernatant 823 
(S) and pellet (P) intensities for that concentration, multiplied by 100. The curves are plotted based on 824 
the average of the two measurements. The bands intensities were quantified using the ImageJ software 825 
(Schneider et al., 2012).  826 
B. Pull-down assays using a varying amount of PGN sacculi against a constant amount of either IntPeri-827 
MBP (upper gel) or InvPeri-MBP (lower gel). The graph depicts relative binding for each PGN amount (in 828 
micrograms). The binding percentage was calculated as for panel A. S = supernatant, P = pellet. 829 
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 831 
Fig. 6. The Int periplasmic domain binds to PGN in vivo. 832 
In vivo binding to peptidoglycan. Cells expressing IntPeri-MBP or InvPeri-MBP periplasmically were 833 
grown at pH 7.4 or pH 5.5. The periplasmic fraction was extraction using a modified osmotic shock 834 
protocol. Samples from whole cells (C) or the periplasmic fraction (P) were separated by SDS-PAGE and 835 
subjected to Western blotting using an anti-MBP antibody. pIBA2C is the vector control, and MBP acts as 836 
a control for periplasmic extraction.  837 
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 839 
Fig. 7. Solution structure of Int LysM 840 
A. Ensemble of 20 acceptable NMR structures for the Int LysM region, showing the LysM itself 841 
(highlighted in red) is well defined whereas the N-terminus and C-terminal spacer sequence are 842 
disordered.  843 
B. The Int LysM structure in cartoon representation. 844 
C. Superposition of of other LysM structures onto the Int LysM NMR structure (in blue). The structures 845 
include bacterial and bacteriophage LysMs (MltD from E. coli in green (PDB 1E0G)); YkuD from B. subtilis 846 
in mauve (1Y7M); gpX from coliphage P2 in salmon (2LTF)), LysMs from fungal protein (LysM1 from Ecp6 847 
of Cladosporium fulvum in yellow (4B8V); LysM of CVNH lectin from Magnaporthe oryzae in cyan 848 
(2L9Y)), a plant protein (LysM1 from AtCERK1 of A. thaliana in grey (4EBY)) and a human hypothetical 849 
protein (SB145 (2DJP)). The major difference in Int LysM compared to the others is the α-helical region 850 
between the C-terminal conserved α-helix and the C-terminal β-strand. The figures were prepared using 851 
VMD (Humphrey et al., 1996, http://www.ks.uiuc.edu/Research/vmd/) 852 
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 854 
Fig. 8. The periplasmic domain of YrInv forms multimers and binds peptidoglycan.   855 
A. Effect of reducing agent on YrInvPeri-MBP. β-ME = β-mercaptoethanol. 856 
B. SEC of YrInvPeri-MBP at pH 7.4 with (magenta) and without DTT(light blue). The inset shows an SDS-857 
PAGE gel of the peaks (no additional reducing agent was added). The expected size for the monomer is 858 
58 kDa. Apparent molecular weights are indicated. The SEC curve for IntPeri-MBP (dashed blue line) is 859 
shown for comparison. 860 
C: PGN binding of YrInvPeri-MBP. Pull-downs with or without PGN sacculi was performed at pH 5.0 or pH 861 
7.4. At pH 5.0, pull-down assays were performed either with or without the addition of 10 mM DTT. The 862 
small amount of monomeric YrInv seen at the edges of lanes 5 and 10 can be explained by diffusion of 863 
the DTT from the neighbouring wells. S = supernatant, P = pellet. 864 
D. Schematic of YrInvPeri periplasmic domain and barrel. The position of the single cysteine in the 865 
spacer sequence is indicated. 866 
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 868 
Fig. 9. Model for Intimin dimerisation and Tir clustering 869 
Schematic of Int (in blue) bound to Tir (red). Dimerisation of Int through the periplasmic domain in the 870 
periplasmic domain leads to a reticular array which promotes Tir clustering and pedestal formation. 871 
Dimerisation takes place at two sites within the periplasmic domain: at the C-terminal α-helix and in the 872 
spacer sequence between the LysM and the N-terminal α-helix. Where structural information is 873 
available, cartoon structures are depicted. Regions of unknown structure are depicted as connecting 874 
lines, or cylinders in the case of α-helices. The actin cortex of the host cell is in green, the peptidoglycan 875 
backbone in brown and peptide crosslinks in light blue. PDB IDs of the structures used for the figure are 876 
1F02, 4E1S and 2MPW. The structural figures were prepared using VMD (Humphrey et al., 1996, 877 
http://www.ks.uiuc.edu/Research/vmd/) 878 
